Allergan stops sales in Europe of breast implants linked to cancer

Allergan stops sales in Europe of breast implants linked to cancer
FILE PHOTO: A sign marks Allergan's offices in Medford, Massachusetts, U.S., July 31, 2017. REUTERS/Brian Snyder -
Euronews logo
Text size Aa Aa

PARIS (Reuters) – Breast implants made by drugmaker Allergan <AGN.N>, which have been linked to a rare form of cancer, are being taken off the market in Europe, said a French regulatory body.

France’s National Agency for the Safety of Medicines & Health Products (ANSM) said in a statement late Tuesday that the decision concerned Allergan’s Microcell and Biocell products.

The French regulator added that it had not identified any immediate risk for the health of women carrying these implants.

Allergan, best known for its Botox and Juvederm products, had said it has been considering a sale of its women’s health and infectious disease businesses. However, the Dublin-based company said in October that the initial offers had been too low.

(Reporting by Sudip Kar-Gupta, Editing by Sherry Jacob-Phillips)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.
Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.